 | Up a level |
2018
Braess, Jan, Amler, Susanne, Kreuzer, Karl-Anton, Spiekermann, Karsten, Lindemann, Hans Walter, Lengfelder, Eva, Graeven, Ullrich, Staib, Peter, Ludwig, Wolf-Dieter, Biersack, Harald, Ko, Yon-Dschun, Uppenkamp, Michael J., De Wit, Maike, Korsten, Stefan, Peceny, Rudolf, Gaska, Tobias, Schiel, Xaver, Behringer, Dirk M., Kiehl, Michael G., Zinngrebe, Bettina, Meckenstock, Gerald, Roemer, Eva, Medgenberg, Dirk, Spaeth-Schwalbe, Ernst, Massenkeil, Gero, Hindahl, Heidrun, Schwerdtfeger, Rainer, Trenn, Guido, Sauerland, Cristina, Koch, Raphael, Lablans, Martin, Faldum, Andreas, Goerlich, Dennis, Bohlander, Stefan K., Schneider, Stephanie, Dufour, Annika, Buske, Christian, Fiegl, Michael, Subklewe, Marion, Braess, Birgit, Unterhalt, Michael, Baumgartner, Anja, Woermann, Bernhard, Beelen, Dietrich and Hiddemann, Wolfgang (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. Leukemia, 32 (12). S. 2558 - 2572. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
2016
Hermine, Olivier 
ORCID: 0000-0003-2574-3874, Hoster, Eva ORCID: 0000-0002-0749-1389, Walewski, Jan ORCID: 0000-0003-4247-2674, Bosly, Andre, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles ORCID: 0000-0002-9541-8666, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Haenel, Mathias, Casasnovas, Rene Olivier, Finke, Juergen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Duehrsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Helene, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael and Dreyling, Martin
(2016).
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet, 388 (10044).
S. 565 - 576.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Hoster, Eva ORCID: 0000-0002-0749-1389, Rosenwald, Andreas, Berger, Francoise, Bernd, Heinz-Wolfram, Hartmann, Sylvia, Loddenkemper, Christoph, Barth, Thomas F. E., Brousse, Nicole, Pileri, Stefano, Rymkiewicz, Grzegorz ORCID: 0000-0002-3478-8014, Kodet, Roman, Stilgenbauer, Stephan, Forstpointner, Roswitha, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Hallek, Michael, Coiffier, Bertrand, Vehling-Kaiser, Ursula, Bouabdallah, Reda, Kanz, Lothar, Pfreundschuh, Michael, Schmidt, Christian, Ribrag, Vincent, Hiddemann, Wolfgang, Unterhalt, Michael, Kluin-Nelemans, Johanna C., Hermine, Olivier ORCID: 0000-0003-2574-3874, Dreyling, Martin H. and Klapper, Wolfram
(2016).
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
J. Clin. Oncol., 34 (12).
S. 1386 - 1396.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Hoster, Eva ORCID: 0000-0002-0749-1389, Klapper, Wolfram, Hermine, Olivier ORCID: 0000-0003-2574-3874, Kluin-Nelemans, Hanneke C., Walewski, Jan ORCID: 0000-0003-4247-2674, van Hoof, Achiel, Trneny, Marek ORCID: 0000-0002-6952-6073, Geisler, Christian H., Di Raimondo, Francesco, Szymczyk, Michal, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Hallek, Michael, Forstpointner, Roswitha, Pott, Christiane, Ribrag, Vincent, Doorduijn, Jeanette, Hiddemann, Wolfgang, Dreyling, Martin H. and Unterhalt, Michael
(2014).
Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network.
J. Clin. Oncol., 32 (13).
S. 1338 - 1347.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Hoster, Eva, Unterhalt, Michael, Pfreundschuh, Michael, Hallek, Michael, Forstpointner, Roswitha, Metzner, Bernd, Einsele, Hermann, Krauter, Juergen, Duehrsen, Ulrich, Ludwig, Wolf-Dieter, Birkmann, Josef, Peter, Norma, Klapper, Wolfram, Dreyling, Martin H. and Hiddemann, Wolfgang (2014). The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients - a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2012
Hermine, Olivier, Hoster, Eva, Walewski, Jan, Ribrag, Vincent, Brousse, Nicole, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Bouabdallah, Reda, Dohner, Hartrnut, Feugier, Pierre, Forspointner, Roswitha, Haioun, Corinne, Kneba, Michael, Haenel, Mathias, Casasnovas, Olivier, Mertelsmann, Roland H., Hallek, Michael, Bosly, Andre, Nowacki, M., Klapper, Wolfram, Gisselbrecht, Christian, Coiffier, Bertrand, Unterhalt, Michael, Hiddemann, Wolfgang and Dreyling, Martin H.
(2012).
Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net).
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971